• 9
    Feb
  • HEPATITIS A VACCINATION AMONG YOUNG AFRICAN AMERICAN MEN: RESULTS

Sample Demographics

Of the 120 MSM participants who completed the survey, 107 self-identified as African American or black; 5 self-identified as Hispanic or Latino; 4, as Native American; 4, as white. Of the 107 African American participants, the mean (± SD) age was 24.8 ± 5.93 years, with a range of 18 to 50 years. The majority of participants reported yearly income of $20,000 or more (61.4%), some college or above (57.9%), and having private health insurance (57.9%).

Hepatitis Risk

Nearly 34% (n = 36) reported being vaccinated against HAY Over half of the participants reported 10 or more different lifetime male sexual partners (n = 69), and fewer than half reported 2 or more different male sexual partners within the past 30 days (n = 43). Nearly a third (n = 32) reported having had intercourse with females as well as males within the past 5 years. Apcalis Oral Jelly

When asked what percent of the time they used condoms during intercourse, 11.3% of the participants reported condom use over half of the time when performing or receiving oral intercourse, and 50% of the participants reported using a condom over half the time during insertive or receptive anal intercourse. Nearly 60% of participants (n = 62) reported engaging in unprotected anal-oral contact (“rimming”).

Over 11% (n = 12) of this sample reported a lifetime history of at least one STD diagnosis, excluding seropositivity for НЩ and 6.5% (n = 7) reported that they had received at least one STD diagnosis within the past five years. Almost 5% (n = 5) reported a positive HIV antibody test result. Almost 6% (n = 6) of the sample reported having received blood or blood products before 1992, and 5.6% (n = 6) reported ever having injected drugs or steroids; only two participants reported ever having shared injecting drug equipment. canadian antibiotics

Table 2. Characteristics Independently Associated With Self-Reported Hepatitis A Vaccination

Characteristic Adjusted Odds Ratio (95% CI) P Value
Practical barriers to HAV vaccination .05 (0.01-0.18) .002
Health care provider communication 9.89 (2.74-35.65) .02
Perceived benefits of HAV vaccination 1.93 (0.63-5.91) .45
Perceived severity of HAV infection 2.24 (0.99-5.08) .21
Perceived susceptibility to HAV infection .71 (0.32-1.60) .59
Perceived general medical self-efficacy
to complete the 2-dose series .95 (0.29-3.09) .95
Perceived personal self-efficacy to complete
the 2-dose series 7.31 (2.38-22.45) .02

ATTITUDES AND BELIEFS ABOUT HAV INFECTION AND VACCINATION

Table 2 displays the odds ratio, 95% confidence interval and significance level between HAV vaccination and the independent contribution of each psychosocial predictor. Of the seven psychosocial predictors entered into the multivariable model, three were associated with HAV vaccination. The predictive power of the model (x2 = 38.07; P = .0001) was high, correctly classifying 80% of the participants into their self-reported vaccination status categories.

Participants who perceived low levels of practical barriers to HAV vaccination were over 90% more likely to be vaccinated against HAV than those who perceived high levels of practical barriers to HAV vaccination. Similarly, participants who reported high levels of health care provider communication about sexual orientation and risk behaviors were over nine times more likely to be vaccinated against HAV Participants who reported high levels of personal self-efficacy to complete the two-dose series were seven times more likely to self-report HAV vaccination than those who reported low levels of personal self-efficacy to complete the series.

Online Pharmacy